By introducing astrocyte co-culture, this study demonstrates that SHH pathway inhibition with cyclopamine stimulates markedly different responses in GBM and their sub-populations, offering new insight into how microenvironmental cues shape treatment outcomes. The gene discussed is SHH; the disease is glioblastoma.